A recent study finds high rates of discordance between trial reporting on ClinicalTrials.gov and corresponding publications. Findings accentuate the need to monitor for accurate reporting.
See “Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA”
CITI Program’s Clinicaltrials.gov Content
Protocol Registration and Results Summary Disclosure in ClinicalTrials.gov provides a video-enhanced guide to compliance with the FDAAA Final Rule and NIH Policy on clinical trial disclosure in ClinicalTrials.gov.
View Course Details
Building a ClinicalTrials.gov Compliance Program – Tips for Investigators and Institutions reviews reporting regulations, covers noncompliance, and discusses how to build a successful compliance monitoring program.
View Webinar Details